Interface dermatitis

Published on 08/03/2015 by admin

Filed under Dermatology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 5 (1 votes)

This article have been viewed 7538 times

Chapter 7

Interface dermatitis

Lichenoid interface dermatitis

Causes of lichenoid interface dermatitis

The biopsy in each of these conditions demonstrates a sawtooth rete ridge pattern with destruction of the basal layer, a band-like lymphoid infiltrate, and presence of Civatte bodies. Compact hyperkeratosis and beaded hypergranulosis are typically present. The cells of the stratum spinosum are enlarged and more eosinophilic than the normal epidermis. Vacuoles may be present in the lowest cells of stratum spinosum, but the basal layer is gone. An underlying band-like lymphoid infiltrate is common.

If neither parakeratosis nor eosinophils are noted, the changes are consistent with lichen planus. Lichenoid interface dermatitis with neither eosinophils nor parakeratosis may also be seen in BLK (lichen planus-like keratosis), lichenoid drug eruption, lichenoid GvHD, hypertrophic lupus erythematosus, and lichenoid regression of lentigo maligna. Clinical correlation is essential. Direct immunofluorescence (DIF) will distinguish hypertrophic lupus erythematosus (continuous granular band of immunoglobulins and complement plus cytoid bodies) from lichen planus (shaggy fibrin, cytoid bodies).

When parakeratosis is present, lichen planus is very unlikely. The differential diagnosis still includes BLK, lichenoid drug eruption, lichenoid GvHD, and lichenoid regression of a melanocytic lesion. Hypertrophic lupus erythematosus rarely demonstrates parakeratosis.

The presence of eosinophils strongly favors a diagnosis of lichenoid drug eruption. The presence of eosinophils weighs strongly against a diagnosis of lichen planus. They are rarely seen in hypertrophic lupus erythematosus, BLK, lichenoid GvHD, or lichenoid regression of a melanocytic lesion.

Hypertrophic lupus erythematosus

Hypertrophic lupus erythematosus is lichenoid histologically. It is distinguished from lichen planus by the DIF pattern, occasional presence of basement membrane zone thickening or dermal mucin, and by clinical history and serologic findings. This is the form of chronic cutaneous lupus erythematosus that is most likely to give rise to invasive squamous cell carcinoma.

Mycosis fungoides

The biopsy demonstrates epidermotropism of large atypical lymphocytes with little accompanying spongiosis. These lymphocytes show some tendency to form small aggregates and to line up along the dermal–epidermal junction. Papillary dermal fibrosis is prominent. The bare underbelly sign refers to the tendency for the superficial perivascular lymphoid infiltrate to predominate above the vessel, with few lymphocytes below the vessel. It has been likened to a vacuum cleaner sucking the lymphocytes towards the surface. Immunostaining and gene rearrangement studies can be helpful. Selective loss of CD7 expression in the atypical intraepidermal lymphocytes is a common finding. As the disease progresses from patch, to plaque, to tumor stage, atypical cells appear in the dermal infiltrate, and epidermotropism is lost.

Differential Diagnosis

The pattern of vacuolar interface dermatitis with a lymphocyte in every vacuole may also be seen in pityriasis lichenoides and the early stage of a BLK. The pattern of large dark nuclei with surrounding vacuoles at the dermal–epidermal junction may also be seen in lentigo maligna and lymphomatoid drug eruption.

Pityriasis lichenoides et varioliformis acuta (PLEVA)

The biopsy demonstrates vacuolar interface dermatitis with a lymphocyte in every vacuole. Keratinocyte necrosis, central ulceration, and crusting may be noted. Erythrocyte extravasation with transepidermal elimination of erythrocytes is common. The infiltrate is purely lymphoid, with a superficial and deep perivascular pattern. Prominent intravascular margination of neutrophils is typical. The infiltrate in PLEVA is characterized by CD8-positive cytotoxic T cells. A clone can often be detected by gene rearrangement studies.

Early stage of benign lichenoid keratosis

Vacuolar interface dermatitis with vacuoles or cell death out of proportion to lymphocytes

Lupus erythematosus

The features of discoid lupus erythematosus appear in a time-dependent fashion. Biopsies of acute lupus erythematosus show only vacuolar interface dermatitis. DIF will usually be negative at this stage. Subacute lesions of lupus erythematosus show vacuolar interface dermatitis, hyperkeratosis, and follicular plugging, as well as a variable dermal infiltrate. DIF is positive in about one-third of cases. Well-established discoid lesions (of at least 3 months’ duration) typically demonstrate strong DIF. Histologically, established discoid lupus erythematosus lesions are characterized by hyperkeratosis, follicular plugging, vacuolar interface dermatitis, basement membrane zone thickening, a patchy superficial and deep perivascular and periadnexal lymphoid infiltrate, and interstitial mucin. Underlying lupus panniculitis may be present.

Fixed drug eruption

The most important diagnostic feature is the mismatch between the normal stratum corneum and chronic changes in the superficial dermis. Fixed drug eruption is episodic. The biopsy is likely to occur during an acute inflammatory phase, but dermal changes from past episodes are present. The result is a normal stratum corneum, consistent with an acute process. In contrast, there is papillary dermal fibrosis, consistent with a chronic process. Pigment has had time to be carried to a perivascular location. The polymorphous infiltrate typically includes eosinophils and may include neutrophils.

Pearl

The normal stratum corneum whispers, “Look at me, I’m an acute process.” The papillary dermal fibrosis and pigment around vessels respond, “Liar! There are chronic changes in the dermis.”

Further reading

Acikalin, A, Bagir, E, Tuncer, I, et al. Contribution of T-cell receptor gamma gene rearrangement by polymerase chain reaction and immunohistochemistry to the histological diagnosis of early mycosis fungoides. Saudi Med J. 2013; 34(1):19–23.

Brönnimann, M, Yawalkar, N. Histopathology of drug-induced exanthems: is there a role in diagnosis of drug allergy? Curr Opin Allergy Clin Immunol. 2005; 5(4):317–321.

Dalton, SR, Chandler, WM, Abuzeid, M, et al. Eosinophils in mycosis fungoides: an uncommon finding in the patch and plaque stages. Am J Dermatopathol. 2012; 34(6):586–591.

Dalton, SR, Fillman, EP, Altman, CE, et al. Atypical junctional melanocytic proliferations in benign lichenoid keratosis. Hum Pathol. 2003; 34(7):706–709.

Demartini, CS, Dalton, MS, Ferringer, T, et al. Melan-A/MART-1 positive “pseudonests” in lichenoid inflammatory lesions: an uncommon phenomenon. Am J Dermatopathol. 2005; 27(4):370–371.

Kaley, J, Pellowski, DM, Cheung, WL, et al. The spectrum of histopathologic findings in cutaneous eruptions associated with influenza A (H1N1) infection. J Cutan Pathol. 2013; 40(2):226–229.

Massone, C, Kodama, K, Kerl, H, et al. Histopathologic features of early (patch) lesions of mycosis fungoides: a morphologic study on 745 biopsy specimens from 427 patients. Am J Surg Pathol. 2005; 29(4):550–560.

Morgan, MB, Stevens, GL, Switlyk, S. Benign lichenoid keratosis: a clinical and pathologic reappraisal of 1040 cases. Am J Dermatopathol. 2005; 27(5):387–392.

Smith, SB, Libow, LF, Elston, DM, et al. Gloves and socks syndrome: early and late histopathologic features. J Am Acad Dermatol. 2002; 47(5):749–754.

Yawalkar, N, Pichler, WJ. Immunohistology of drug-induced exanthema: clues to pathogenesis. Curr Opin Allergy Clin Immunol. 2001; 1(4):299–303.

Zhang, Y, Wang, Y, Yu, R, et al. Molecular markers of early-stage mycosis fungoides. J Invest Dermatol. 2012; 132(6):1698–1706.